Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Atarax (hydroxyzine hcl) Treatment Report
What is Atarax?

Atarax is a brand name for Hydroxyzine. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Itching (pruritus) 7 3
Other 3 1
1/2 pill after injection to help with reaction 1 0
Anxiety 1 0
Sleep problems 1 0
Memory problems 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 25%
Moderate
0 0%
Mild
2 50%
None
1 25%

Most commonly reported side effects

Drowsiness
3 75%
  • Mild
  • Moderate
  • Severe

Dosages

  10mg as needed 25mg as needed hydrochloride25mg as needed hydrochloride 10 mg/5 mL daily 25 mg daily 50 mg daily 75 mg daily 100 mg daily 300 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Atarax (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%
Doctor's advice
1 50% Doctor's advice: 50%

See all 2 patients who’ve stopped taking Atarax

Currently Taking Atarax

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
1
1
3

Stopped Taking Atarax

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
1
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 50%
Usually
1 25%
Sometimes
1 25%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 25%
Not at all
3 75%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.